We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 34 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Oct 08, 2025～Nov 04, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Oct 08, 2025～Nov 04, 2025
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. null/null
  3. スペラファーマ Osaka//others
  4. 4 null/null
  5. 5 立山化成 Toyama//Manufacturing and processing contract
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Oct 08, 2025～Nov 04, 2025
This ranking is based on the number of page views on our site.

  1. [Research Material] The Global Market for Neglected Tropical Disease (NTD) Treatments マーケットリサーチセンター
  2. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  3. For various titrations! The titration "indicator" specified in JIS K8001. 関東化学株式会社 バイオケミカル部
  4. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  5. Tateyama Kasei Co., Ltd. Kyushu Factory 立山化成

medicine Product List

196～210 item / All 595 items

Displayed results
[Research Material] Global Market for Hepatic Encephalopathy (HE) Treatment Drugs

[Research Material] Global Market for Hepatic Encephalopathy (HE) Treatment Drugs

Global Market for Hepatic Encephalopathy (HE) Treatments: Lactulose, Rifaximin, Neomycin, Probiotics, Thiamine, Acute Liver Failure, Liver Cirrhosis

This research report (Global Hepatic Encephalopathy (HE) Therapeutics Market) investigates and analyzes the current status and outlook for the global market of hepatic encephalopathy (HE) therapeutics over the next five years. It includes information on the global hepatic encephalopathy (HE) therapeutics market overview, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for hepatic encephalopathy (HE) therapeutics by type include lactulose, rifaximin, neomycin, probiotics, and thiamine, while the segments by application focus on acute liver failure and cirrhosis. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for hepatic encephalopathy (HE) therapeutics. It also includes the market share of major companies in the hepatic encephalopathy (HE) therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Ischemic Stroke Treatment Drugs

[Research Material] Global Market for Ischemic Stroke Treatment Drugs

Global Market for Ischemic Stroke Treatment Drugs: Tissue Plasminogen Activator, Anticoagulants, Antiplatelet Agents, Antihypertensives, Others, Hospitals, Clinics, Outpatient ...

This research report (Global Ischemic Stroke Drugs Market) investigates and analyzes the current state and outlook for the global market of ischemic stroke treatment drugs over the next five years. It includes information on the overview of the global ischemic stroke treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include tissue plasminogen activators, anticoagulants, antiplatelet agents, antihypertensives, and others, while the segments by application focus on hospitals, clinics, outpatient surgery centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for ischemic stroke treatment drugs. The report also includes the market share of major companies in the ischemic stroke treatment drugs sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Cachexia Treatment

[Research Material] The Global Market for Cachexia Treatment

World Market for Cachexia Treatment: Weight Stabilizers, Appetite Stimulants, Progestogens, Corticosteroids, Combination Therapy, Others, Hospital Pharmacies, Retail Pharmacies, ...

This research report (Global Cachexia Treatment Market) investigates and analyzes the current state and future outlook of the global cachexia treatment market over the next five years. It includes information on the overview of the global cachexia treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the cachexia treatment market include weight stabilizers, appetite stimulants, progestogens, corticosteroids, combination therapies, and others, while the segments by application target hospital pharmacies, retail pharmacies, drugstores, and online. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for cachexia treatment. It also includes the market share of major companies in cachexia treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Tumor Treatment Drugs

[Research Material] Global Market for Tumor Treatment Drugs

Global Market for Tumor Treatment Drugs: Chemotherapy, Targeted Therapy, Immunotherapy (Biological Therapy), Hormonal Therapy, Others, Hematological Cancers, Breast Cancer, Gastrointestinal Cancers, ...

This research report (Global Oncology Drugs Market) investigates and analyzes the current status and outlook for the global market of oncology drugs over the next five years. It includes information on the overview of the global oncology drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the oncology drugs market include chemotherapy, targeted therapy, immunotherapy (biological therapy), hormone therapy, and others, while the segments by application cover hematologic cancers, breast cancer, gastrointestinal cancers, prostate cancer, respiratory cancers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of oncology drugs. It also includes the market share of major companies in oncology drugs, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Non-Hodgkin Lymphoma Treatment Drugs

[Research Material] Global Market for Non-Hodgkin Lymphoma Treatment Drugs

World Market for Non-Hodgkin Lymphoma Treatment Drugs: Chemotherapy, Targeted Therapy, Clinical Research, Treatment

This research report (Global Non-Hodgkin Lymphoma Therapeutics Market) investigates and analyzes the current status and outlook for the global market of non-Hodgkin lymphoma therapeutics over the next five years. It includes information on the overview of the global non-Hodgkin lymphoma therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on chemotherapy and targeted therapy, while the segments by application target clinical research and treatment. The regional segments calculate the market size of non-Hodgkin lymphoma therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in non-Hodgkin lymphoma therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment Drugs for Dilated Cardiomyopathy

[Research Material] Global Market for Treatment Drugs for Dilated Cardiomyopathy

Global Market for Treatment of Dilated Cardiomyopathy: Aldosterone Antagonists, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor ...

This research report (Global Dilated Cardiomyopathy Therapeutic Market) investigates and analyzes the current state and future outlook of the global market for dilated cardiomyopathy therapeutics over the next five years. It includes information on the overview of the global dilated cardiomyopathy therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include aldosterone antagonists, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and beta-blockers, while the segments by application focus on hospitals and academic institutions. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for dilated cardiomyopathy therapeutics. The report also includes the market share of major companies in the dilated cardiomyopathy therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Ebola Treatment

[Research Material] The Global Market for Ebola Treatment

Global Market for Ebola Treatment: Vaccines (in trials), Drugs (in trials), Hospitals, Outpatient Surgery Centers, Specialized Clinics, Army Camps (Veteran Facilities)

This research report (Global Ebola Treatment Market) investigates and analyzes the current state and outlook for the global Ebola treatment market over the next five years. It includes information on the overview of the global Ebola treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Ebola treatment market focus on vaccines (in trials) and drugs (in trials), while the segments by application target hospitals, outpatient surgery centers, specialty clinics, and military camps (veteran facilities). The regional segments calculate the market size for Ebola treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in Ebola treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Myocardial Infarction Treatment Drugs

[Research Material] Global Market for Myocardial Infarction Treatment Drugs

Global Market for Myocardial Infarction Treatment Drugs: JVS-200, KR-33028, AMRS-001, ANG-4011, Balixafortide, CA ...

This research report (Global Myocardial Infarction Drug Market) investigates and analyzes the current state and outlook for the global market for myocardial infarction treatment drugs over the next five years. It includes information on the overview of the global myocardial infarction treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include JVS-200, KR-33028, AMRS-001, ANG-4011, Valiciclovir, CAP-1002, Sendelicitide, and others, while the segments by application focus on research centers, hospitals, and clinics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for myocardial infarction treatment drugs. It also includes the market share of major companies in the myocardial infarction treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Mucopolysaccharidosis Treatments

[Research Material] Global Market for Mucopolysaccharidosis Treatments

World Market for Mucopolysaccharidosis Treatments: Intravenous Injection, Intracerebroventricular (ICV), Hospitals, Clinics, Others

This research report (Global Mucopolysaccharidosis Therapeutics Market) investigates and analyzes the current status and outlook for the global market for mucopolysaccharidosis therapeutics over the next five years. It includes information on the overview of the global mucopolysaccharidosis therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on intravenous injection and intracerebroventricular (ICV) administration, while the segments by application target hospitals, clinics, and others. The regional segments calculate the market size for mucopolysaccharidosis therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in mucopolysaccharidosis therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Troprostenil Therapeutics

[Research Material] Global Market for Troprostenil Therapeutics

World Market for Treprostinil Therapeutics: Remodulin, Tyvaso, Orenitram, Hospitals, Clinics

This research report (Global Treprostinil Drugs Market) investigates and analyzes the current state and outlook for the global market of treprostinil therapeutic drugs over the next five years. It includes information on the overview of the global treprostinil therapeutic drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Remodulin, Tyvaso, and Orenitram, while the segments by application focus on hospitals and clinics. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of treprostinil therapeutic drugs. It also includes the market share of major companies in the treprostinil therapeutic drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Acute Respiratory Distress Syndrome Treatments

[Research Material] Global Market for Acute Respiratory Distress Syndrome Treatments

Global Market for Acute Respiratory Distress Syndrome Treatments: Methylprednisolone, Hydrocortisone, Injectable Bovine Lung Surfactant, Others, Hospitalized Patients ...

This research report (Global Acute Respiratory Distress Syndrome Therapeutics Market) investigates and analyzes the current state and outlook for the global market for acute respiratory distress syndrome therapeutics over the next five years. It includes information on the overview of the global acute respiratory distress syndrome therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the acute respiratory distress syndrome therapeutics market include methylprednisolone, hydrocortisone, injectable bovine lung surfactant, and others, while the segments by application focus on inpatients and outpatients. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for acute respiratory distress syndrome therapeutics. It also includes the market share of major companies in the acute respiratory distress syndrome therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Smoking Cessation Medications

[Research Material] Global Market for Smoking Cessation Medications

Global Market for Smoking Cessation Medications: NRT Products, Nicotine-Free Products, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Smoking Cessation Drugs Market) investigates and analyzes the current state of the global market for smoking cessation drugs and its outlook for the next five years. It includes information on the overview of the global smoking cessation drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the smoking cessation drug market focus on NRT products and nicotine-free products, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size for smoking cessation drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the smoking cessation drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Treatment of Factor VIII Deficiency

[Research Material] The Global Market for Treatment of Factor VIII Deficiency

World Market for Treatment of Factor VIII Deficiency: Hemophilia A Drugs, Hemophilia A Inhibitor Treatment, von Willebrand Disease Treatment, Hospitals, Clinics, Others

This research report (Global Factor VIII Deficiency Treatment Market) investigates and analyzes the current status and outlook for the global market for Factor VIII deficiency treatment over the next five years. It includes information on the overview of the global Factor VIII deficiency treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Factor VIII deficiency treatment market focus on hemophilia A drugs, hemophilia A inhibitor treatments, and von Willebrand disease treatments, while the segments by application target hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for Factor VIII deficiency treatment. It also includes the market share of major companies in Factor VIII deficiency treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Smooth Muscle Sarcoma Treatment Drugs

[Research Material] Global Market for Smooth Muscle Sarcoma Treatment Drugs

World Market for Smooth Muscle Tumor Treatment Drugs: AL-3818, BGB-290, C-21, Others, Clinics, Hospitals, Others

This research report (Global Leiomyosarcoma Drug Market) investigates and analyzes the current state and outlook for the global market of smooth muscle sarcoma treatment drugs over the next five years. It includes information on the overview of the global smooth muscle sarcoma treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include AL-3818, BGB-290, C-21, and others, while the segments by application focus on clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of smooth muscle sarcoma treatment drugs. It also includes the market share of major companies in the smooth muscle sarcoma treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Chronic Bronchitis Treatment

[Research Material] The Global Market for Chronic Bronchitis Treatment

Global Market for Chronic Bronchitis Treatment: Antibiotics, Anti-inflammatory Drugs, Bronchodilators, Mucolytics, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Chronic Bronchitis Treatment Market) investigates and analyzes the current state and outlook for the global chronic bronchitis treatment market over the next five years. It includes information on the overview of the global chronic bronchitis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the chronic bronchitis treatment market focus on antibiotics, anti-inflammatory drugs, bronchodilators, and mucolytics, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size for chronic bronchitis treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in chronic bronchitis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.